Northeast Region Conference 2010
Tuesday, April 13th Program:
Management
Jeff Jacobs is associate executive director for special
programs, Association of Public Health Laboratories and vice president
of Public Policy, American Society for Clinical Pathology (ASCP).
Lucia Berte is a consultant with Laboratories Made Better!
P.C. in Broomfield Colorado. She is health care professional who
has specialized in quality management systems in health care ancillary
services for almost 20 years, She is committed to reducing laboratory
problems that affect quality and patient safety.
P. Thomas Hirsch has had extensive experience in the management
and operations of hospital and independent laboratories. He is
currently co-founder and president of Laboratory Billing Solutions,
a company that performs billing services for hospital outreach
and smaller independent laboratories. He was president and chief
executive officer of Path Lab Inc. from June 1984 through February
2003, a highly successful hospital-based independent laboratory.
The company was sold to LabCorp in April 2001 for more than $100
million
Quality
Charity M. Robbins CPC, CMPAM is Manager, BRL Revenue
Cycle
Jason Newmark is Director, Diagnostic Services Baystate
Health, Springfield Massachusetts
Glenn Surprenant is Senior Manager Diagnostic Services
Baystate Medical Center, Springfield Massachusetts
Sharon Scott is Quality Management Coordinator, Baystate
Medical Center, Springfield Massachusetts
Marketing & Planning
Daniella Priebatsch has been a member of the Google AdWords
division for three years. As an AdWords Account Manager, Daniella
helps Healthcare companies develop strategic integrated marketing
plans that support their online and offline advertising goals.
Prior to joining Google, Danielle graduated with a BA in American
Studies from Brown University.
Microchip Diagnostics
Anubhave Tripathi, Ph.D., is an associate professor in
the division of engineering and the division of biological sciences
and medical school (courtesy) at Brown University. His experience
in research and development builds from six years at Brown University
as faculty, three years at Caliper LifeSciences (Hopkinton, MA)
as a research scientist, a year at San Jose State University as
a part-time instructor, two years at Massachusetts Institute of
Technology (MIT) as a postdoctoral associate and five years at
the Levich Institute, City University of New York as a graduate
student. At Brown, he also serves as co-director of the center
for biomedical engineering. His research thrust is in biomedical
engineering particularly focusing on disease detection and diagnostics
through translational research. His current research collaborations
with Memorial Hospital on influenza subtype detection, with Miriam
Hospital on K103N HIV detection, with Rhode Island Hospital on
Clostridium difficile, and with Women and Infants Hospital on
3D culture for in-vitro fertilization
Autoimmune Disease
Eric S. Hoy Ph.D., earned his degree in Pathology from
the University of Illinois College of Medicine in Chicago. He
has been involved in Laboratory Medicine and Pathology for over
30 years. Dr. Hoy is currently a Clinical Associate Professor
at the University of Texas Southwestern Medical Center at Dallas,
where he teaches Basic Immunology, Clinical Immunology, and Molecular
Biology in the Department of Medical Laboratory Sciences. Dr.
Hoy's major interest in the field of Clinical Immunology is Autoimmune
Diseases.
Emerging Technologies
Chris Williams
Scott Kuzdzal, Ph.D., received his Ph.D. in Analytical
Chemistry in 1997 from the University of California at Riverside.
He served as a postdoctoral fellow at the Johns Hopkins University
School of Medicine, where he co-founded and directed the Johns
Hopkins Center for Biomarker Discovery with
Salvatore J Salamone, Ph.D. has over 25 years experience
in the health care and medical device industries. Prior to founding
Saladax, Dr Salamone was Vice President of Research and Development,
Roche Diagnostics, where he was responsible for North American
research and development efforts for the Laboratory Systems Division.
Dr Salamone's efforts during his 17-year tenure at Roche resulted
in the launch of 7 major reagent product platforms, comprised
of over 70 products and more than 200 instrument applications.
Dr Salamone is well known in the field of drug management with
well over 100 publications, including textbook chapters, books,
patents, and articles in the area. Dr. Salamone received 2 bachelor's
degrees from Villanova University, a master's and a Ph.D. degree
from Rutgers University, and was a SERC Post-Doctoral Fellow at
Oxford University.
Raymond Y Kwong MD MPH FACC, is Director of Cardiac Magnetic
Resonance Imaging, Brigham and Women's Hospital, Boston, MA.,
and Assistant Professor of Medicine Harvard Medical School. He
earned his undergraduate degree in Chemistry from the University
of Toronto in 1988. He graduated from Medical School at the University
of Toronto in 1992. He did his internship at St. Josephs Health
Center, University of Toronto and his residency at Vancouver General
Hospital, University of British Columbia. He completed a Cardiovascular
Fellowship at George Washington University Medical Center and
a Post Doc Fellowship at the National Institutes of Health.
Dr. Hickey
Phlebotomy
Jonathan Park, Ph.D., CG(ASCP)CM is the AGT Representative
to the ASCP Board of Certification (BOC) Board of Governors
Sue Antel
Michele Baker
Lori Zanin, MLS (ASCP) is the Laboratory Manager at Milton
Hospital, a clinical affiliate of Beth Israel Deaconess Medical
Center in Milton, Massachusetts. Lori also served as Chemistry
and Hematology Section Head at Memorial Hospital of Rhode Island.
Lori has been working the turn around time of AM draws as a performance
improvement initiative for the last three years.
Dr. Stacy E.F. Melanson received her MD and PhD from
Tufts University School of Medicine in Boston, MA. She completed
her residency in Clinical Pathology at Massachusetts General Hospital
in Boston, MA. She is currently an Assistant Professor of Pathology
at Harvard Medical School and the Associate Medical Director of
Clinical Chemistry, the Medical Director of Phlebotomy, the Medical
Director of the BWH Laboratory at BWH/Mass General Health Care
Center and the Medical Director of Point of Care Testing at Brigham
and Women's Hospital in Boston, MA. She is actively involved in
ongoing projects related to process improvement in phlebotomy
such as improvement of inpatient phlebotomy rounding and communication,
benefits of electronic positive patient identification and implementation
of an electronic system to communicate physician orders with the
laboratory information system. Her most recent article on process
improvement, which describes new workflow for outpatient phlebotomy
services, is in press in the American Journal of Clinical Pathology
Mary Ellen Cortizas, PBT(ASCP), JD is Administrative
Director of Laboratory Medicine at Children's Hospital Boston,
and teaches the Laboratory Management course in Northeastern's
Clinical Laboratory Science program
EVENING DINNER AND LECTURE
Daniel W. Chan, Ph.D., DABCC, FACB, is the Director of
the Clinical Chemistry Division and Co-Director of the Pathology
Core Lab of the Johns Hopkins Hospital and Professor of Pathology,
Oncology, Radiology, and Urology and the Director of the Center
for Biomarker Discovery at the Johns Hopkins University School
of Medicine. He has served on the Board of Directors of the National
Academy of Clinical Biochemistry, President of the National Registry
in Clinical Chemistry and the Chair of the Proteomics Division
in the American Association for Clinical Chemistry. He is a founder
and a member of the Board of Directors of USHUPO. He is a senior
editor of Cancer Epidemiology Biomarkers & Prevention and the
Editor-in-Chief of Clinical Proteomics. Dr. Chan is an internationally
recognized expert on clinical proteomics, biochemical tumor markers,
and immunoassay. Dr. Chan has edited and written 5 books on tumor
markers, immunoassay and automation and published over 250 scientific
articles.
Wednesday, April 14th Program:
Management
Paul D. Camara, MS, is the Vice President , Clinical consulting,
Applied Management Systems, Inc in Burlington Ma. He brings over
25 years of progressive healthcare management experience to AMS.
His expertise includes direction of clinical laboratories as well
as diagnostic imaging, cardiology, and radiation oncology departments.
Sharon Brommer, MS, MBA FACHE, is a senior manager at
Applied Management Systems, inc., Burlington, Massachusetts
Quality
Janet Johnson
Nancy Smith is Senior Director of Patient Care Howard
County General Hospital, part of John Hopkins Medicine
James H. Nichols, Ph.D., DABCC, FACB is Professor of
Pathology, Tufts University School of Medicine and Medical Director,
Clinical Chemistry Baystate Health, Springfield, Massachusetts.
Nicholas Brown
POCT WORKSHOP: How Do We Achieve Concordance
Between POCT and Central Lab Test Results
Jeffrey A. DuBois, Ph.D. FACB is Vice President of Medical
and Scientific Affairs at Nova Biomedical in Waltham Massachusetts.
William A. Clarke, Ph.D., MBA, DABCC is Assistant Professor
and Director Point of Care Testing and TDM Toxicology, Department
of Pathology, Johns Hopkins School of Medicine, Baltimore Maryland.
Martha E Lyon, Ph.D., DABCC, FACB Is Section Head for
Neonatal and Pediatric Clinical Biochemistry and Point of Care
Testing, Alberta Children's Hospital, Calgary, Alberta Canada.
She is also Associate Professor Departments of Pathology and Laboratory
Medicine, Pharmacology and Physiology, and Pediatrics, University
of Calgary, Calgary, Alberta, Canada.
Biomarkers
Geralyn M Lambert-Messerlian, Ph.D. is Associate Director
Division of Prenatal and Special Testing Women and infants Hospital,
Providence RI. She is also Associate Professor in Pathology and
Laboratory Medicine, Brown University School of Medicine.
Emerging Technologies
Narasimhan Nagan, Ph.D., FACMG, DABCC, Genzyme Genetics
Molecular Diagnostic Laboratory Westborough, MA
Jeffrey Chance, Ph.D. is currently a Senior Clinical
Scientist in the Medical & Scientific Affairs and Clinical Operations
department of BD Diagnostics - Preanalytical Systems. In this
role, he is responsible for leading clinical evaluations of blood
collection tubes, including risk assessments for new technologies
and material changes, design of clinical testing plans, and managing
clinical trials from initial feasibility studies through validation
and regulatory submission. Dr. Chance joined BD after completing
the Clinical Chemistry Postdoctoral Training Program at the Johns
Hopkins Medical Institutions in 1999. He received his Ph.D. in
Analytical Chemistry from McGill University in 1997
Dawn Robertson, MT(ASCP)SH, her career has been in the
clinical laboratory until a recent career change to join the Beckman
Coulter team. She have been a Hematology tech, Hematology Supervisor,
Laboratory Supervisor and most recently a Laboratory Manager.
She went to school at the University of Nebraska, where studying
and attending football games, of course, were the top priorities
(Go Big Red!) The majority of her career has been in Colorado
where she have been involved in supporting Clinical Lab Science
in a number of capacities over the years. She pursued her Specialist
in Hematology because she has always loved learning, teaching
and simply enjoying the fascinating aspects of Hematology and
medicine in general.
Denise L. Uettwiller-Geiger, PhD, MT(ASCP), DLM(ASCP),
is Director of Laboratories, Director of Clinical Research, and
a Clinical Chemist in the Clinical Laboratories of John T. Mather
Memorial Hospital (Port Jefferson, NY). She has authored articles,
abstracts, and book chapters on subjects including laboratory
management, laboratory automation, patient safety, cardiac markers,
endocrinology, and immunoassays. She is a Past President for the
Clinical Ligand Society, and in 2001 was nominated for the Woman
of Distinction Award from the First Senate District in New York
State. Her clinical research interests have focused in the areas
of infectious disease, cardiac markers, and fertility. She has
served as principal investigator for numerous clinical trials.
Phlebotomy
Kathleen Finnegan M.S. MT(ASCP)SH, holds the title of
Clinical Associate Professor in the department of Clinical Laboratory
Sciences at Stony Brook University of New York. She received her
bachelor degree from SUNY@ Stony Brook in Clinical Laboratory
Sciences and her master's degree from C.W. Post in Medical Biology.
Her many years of clinical experience were at a small community
hospital. She has 20 years of teaching and is the chair of the
Clinical Laboratory Sciences program. She is board certified with
the American Society of Clinical Pathologists (ASCP) and has her
specialist in hematology (SH). Other accomplishments include,
she has been a contributor of chapters in "Saunders Manual of
Clinical Laboratory Sciences by Craig Lehmann, Hematology in Practice
by Betty Ciesla, and Clinical Hematology and Fundamentals in Hemostasis
by Denise Harmening. She also has published articles and case
studies in field related journals and is an invited speaker for
ASCP workshops. Her talks are at the local, state, national and
international level. She also had the opportunity to teach phlebotomy
in Africa.
Becky Socha works in clinical laboratory and nutritional
sciences at the University of Massachusetts (Lowell Campus)
|